SPARC and cancer: Figure 1 shows the immunostaining patterns and scoring positive staining for each common cancer antigen and HLA class I. SPARC was additionally expressed in the cytoplasm of cancer-associated fibroblasts (CAFs) in addition to cancer cell cytoplasm, suggesting potential therapeutic relevance for targeting SPARC in both cancer cells and CAFs [47,48,49,50,51].